Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole From Subcutaneous Testosterone and Anastrozole (T+Ai) in Premenopausal Women

NCT03314298 is registered in ClinicalTrials.gov with Havah Therapeutics Pty Ltd as lead sponsor.

NCT NCT03314298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03314298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole From Subcutaneous Testosterone and Anastrozole (T+Ai) in Premenopausal Women
Lead sponsor
Havah Therapeutics Pty Ltd
Phase
Phase 1
Overall status
Completed
Start date
August 14, 2017
Completion date
April 17, 2018
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mammographic density